Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of anti-inflammatory effects of two NSAID eye drops after phacoemulsification cataract surgery
ChiCTR2200061802Phase 4Completed
- Sponsor
- Qingdao Eye Hospital of Shandong First Medical University
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in senile cataract (ARC), Postoperative ocular inflammation and dry eye syndrome (DED) comparing 0.1% bromfenac sodium eye drops with 0.1% pranoprofen eye drops (2 arms). Primary endpoints: Inflammatory biomarkers, Clinical symptoms and 2 more. Started Sep 2020; status: completed.
02
Drugs
bromfenac sodiumpranoprofen
03
Conditions
senile cataract (ARC)Postoperative ocular inflammationdry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2200061802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061802.